Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.

[1]  J. Schøller,et al.  In situ detection of HY-specific T cells in acute graft-versus-host disease-affected male skin after sex-mismatched stem cell transplantation. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[2]  S. Mccarroll,et al.  Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease , 2009, Nature Genetics.

[3]  E. Warren,et al.  Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  R. Brand,et al.  Female‐Versus‐Male Alloreactivity as a Model for Minor Histocompatibility Antigens in Hematopoietic Stem Cell Transplantation , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  L. Hambach,et al.  Risk assessment in haematopoietic stem cell transplantation: minor histocompatibility antigens. , 2007, Best practice & research. Clinical haematology.

[6]  F. Claas,et al.  A Uniform Genomic Minor Histocompatibility Antigen Typing Methodology and Database Designed to Facilitate Clinical Applications , 2006, PloS one.

[7]  Y. Aizawa,et al.  Mismatch of minor histocompatibility antigen contributes to a graft-versus-leukemia effect rather than to acute GVHD, resulting in long-term survival after HLA-identical stem cell transplantation in Japan , 2006, Bone Marrow Transplantation.

[8]  S. Böhringer,et al.  Matching of the Minor Histocompatibility Antigen HLA-A1/H-Y May Improve Prognosis in Corneal Transplantation , 2006, Transplantation.

[9]  Y. Heike,et al.  Monitoring of WT1‐specific cytotoxic T lymphocytes after allogeneic hematopoietic stem cell transplantation , 2006, International journal of cancer.

[10]  D. Porter,et al.  Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[11]  Jeffrey K. Mito,et al.  The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL. , 2006, Blood.

[12]  J. Falkenburg,et al.  Human cytotoxic T lymphocytes specific for a single minor histocompatibility antigen HA-1 are effective against human lymphoblastic leukaemia in NOD/scid mice , 2006, Leukemia.

[13]  M. Leppert,et al.  A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia. , 2005, The Journal of clinical investigation.

[14]  L. Hambach,et al.  Immunotherapy of cancer through targeting of minor histocompatibility antigens. , 2005, Current opinion in immunology.

[15]  C. Poremba,et al.  Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8+ T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targets. , 2004, Blood.

[16]  Ming-Tseh Lin,et al.  Disparity for a newly identified minor histocompatibility antigen, HA‐8, correlates with acute graft‐versus‐host disease after haematopoietic stem cell transplantation from an HLA‐identical sibling , 2003, British journal of haematology.

[17]  T. Naoe,et al.  Identification of a Polymorphic Gene, BCL2A1, Encoding Two Novel Hematopoietic Lineage-specific Minor Histocompatibility Antigens , 2003, The Journal of experimental medicine.

[18]  Els Goulmy,et al.  Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  E. Montserrat,et al.  Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblings. , 2002, Blood.

[20]  H. Rammensee,et al.  Induction of HA‐1‐specific cytotoxic T‐cell clones parallels the therapeutic effect of donor lymphocyte infusion , 2002, British journal of haematology.

[21]  A. Grañena,et al.  Disparity for the minor histocompatibility antigen HA‐1 is associated with an increased risk of acute graft‐versus‐host disease (GvHD) but it does not affect chronic GvHD incidence, disease‐free survival or overall survival after allogeneic human leucocyte antigen‐identical sibling donor transplanta , 2001, British journal of haematology.

[22]  Anajane G. Smith,et al.  Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation. , 1999, Blood.

[23]  P. Moss,et al.  Tetrameric HLA class I–minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease , 1999, Nature Medicine.

[24]  C. Figdor,et al.  A Human Minor Histocompatibility Antigen Specific for B Cell Acute Lymphoblastic Leukemia , 1999, The Journal of experimental medicine.

[25]  H. V. van Houwelingen,et al.  Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. , 1996, The New England journal of medicine.

[26]  J. Falkenburg,et al.  Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones. , 1994, Blood.

[27]  A. Bakker,et al.  Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. , 1992, Journal of immunology.

[28]  A. Rimm,et al.  Graft-versus-leukemia reactions after bone marrow transplantation. , 1990, Blood.

[29]  G. Flandrin.  Cytomorphological classification and cytochemistry of acute leukaemias. , 1989, Bone marrow transplantation.

[30]  K. Sullivan,et al.  Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. , 1980, The American journal of medicine.

[31]  P. Neiman,et al.  CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.

[32]  F. Vyth-Dreese,et al.  Exogenous Addition of Minor H Antigen HA-1+ Dendritic Cells to Skin Tissues Ex Vivo Causes Infiltration and Activation of HA-1-Specific Cytotoxic T Cells. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[33]  R. Brand,et al.  Graft-versus-host driven graft-versus-leukemia effect of minor histocompatibility antigen HA-1 in chronic myeloid leukemia patients , 2010, Leukemia.

[34]  Marcos González,et al.  Minor histocompatibility antigen HA-8 mismatch and clinical outcome after HLA-identical sibling donor allogeneic stem cell transplantation. , 2005, Haematologica.

[35]  T. Schumacher,et al.  In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens , 2002, Nature Medicine.

[36]  H. V. van Houwelingen,et al.  Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants. , 2001, The hematology journal : the official journal of the European Haematology Association.